2013Guoji mazuixue yu fusu zazhiRequires access

Selection of the most effective small interfering RNA which inhibits the expression of caveolin-1 in endothelial cells and detection of the cytotoxicity of transfection complex

Huayue Liu, Fuhai Ji

Open publisher page 0 citations

Abstract

Objective Aim to pick out the small interference RNA (siRNA) which could most effectively inhibit the expression of caveolin-1 in endothelial cells and to detect the cytotoxicity of the transfection complex.Methods Four siRNAs were chemically synthesized:siRNA422,siRNA548,siRNA710 were used to inhibit caveolin-1 expression in endothelial cells,FAM-labeled mismatch siRNA was as a negative control They were all transfected into endothelial cells,respectively.Caveolin-1 mRNA was detected after transfection by real-time PCR and its protein expression was measured by Western blot.The cytotoxicity was analyzed with the method of the sulforhodamine B (SRB).Results ① The transfecfon rates are all above 85% under the transfection condition of siRNA(20,30 nmol/L or 40 nmol/L) combined with the same dose of siRNAFect(P<0.01).② The survival rates of transfected cells are all above 80% under the transfection condition of siRNAFect 1.3 μl combined with siRNA (10 nmol/L or 20 nmol/L)(P<0.05).③ The expression of caveolin-1 mRNA in EA.hy926 cells was significantly decreased after siRNA548 treatment (P<0.01).④ Compared with siRNA422,siRNA710,vehicle or mismatch siRNA-treated group,the expression of caveolin-1 protein was the least after siRNA548 treatment 48 h later(P<0.01).Conclusions ① The siRNA548 can inhibit caveolin-1 expression most effectively in endothelial cells.② siRNA(20 nmol/L) combined with siRNAFect(1.3 μl) has lower cytotoxicity and higher transfection efficiency,which is suitable for transfection. Key words: Endothelial cells;  Caveolin-1 ;  Small interfering RNA;  Sulforhodamine B;  Cytotoxicity;  Election

About this research paper

What this paper is about

Objective Aim to pick out the small interference RNA (siRNA) which could most effectively inhibit the expression of caveolin-1 in endothelial cells and to detect the cytotoxicity of the transfection complex.Methods Four siRNAs were chemically synthesized:siRNA422,siRNA548,siRNA710 were used to inhibit caveolin-1 expression in endothelial cells,FAM-labeled mismatch siRNA was as a negative control They were all transfected into endothelial cells,respectively.Caveolin-1 mRNA was detected after transfection by real-time PCR and its protein expression was measured by Western blot.The cytotoxicity was analyzed with the method of the sulforhodamine B (SRB).Results ① The transfecfon rates are all above 85% under the transfection condition of siRNA(20,30 nmol/L or 40 nmol/L) combined with the same dose of siRNAFect(P<0.01).② The survival rates of transfected cells are all above 80% under the transfection condition of siRNAFect 1.3 μl combined with siRNA (10 nmol/L or 20 nmol/L)(P<0.05).③ The expression of caveolin-1 mRNA in EA.hy926 cells was significantly decreased after siRNA548 treatment (P<0.01).④ Compared with siRNA422,siRNA710,vehicle or mismatch siRNA-treated group,the expression of caveolin-1 protein was the least after siRNA548 treatment 48 h later(P<0.01).Conclusions ① The siRNA548 can inhibit caveolin-1 expression most effectively in endothelial cells.② siRNA(20 nmol/L) combined with siRNAFect(1.3 μl) has lower cytotoxicity and higher transfection efficiency,which is suitable for transfection. Key words: Endothelial cells;  Caveolin-1 ;  Small interfering RNA;  Sulforhodamine B;  Cytotoxicity;  Election

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective Aim to pick out the small interference RNA (siRNA) which could most effectively inhibit the expression of caveolin-1 in endothelial cells and to detect the cytotoxicity of the transfection complex.Methods Four siRNAs were chemically synthesized:siRNA422,siRNA548,siRNA710 were used to inhibit caveolin-1 expression in endothelial cells,FAM-labeled mismatch siRNA was as a negative control They were all transfected into endothelial cells,respectively.Caveolin-1 mRNA was detected after transfection by real-time PCR and its protein expression was measured by Western blot.The cytotoxicity was analyzed with the method of the sulforhodamine B (SRB).Results ① The transfecfon rates are all above 85% under the transfection condition of siRNA(20,30 nmol/L or 40 nmol/L) combined with the same dose of siRNAFect(P<0.01).② The survival rates of transfected cells are all above 80% under the transfection condition of siRNAFect 1.3 μl combined with siRNA (10 nmol/L or 20 nmol/L)(P<0.05).③ The expression of caveolin-1 mRNA in EA.hy926 cells was significantly decreased after siRNA548 treatment (P<0.01).④ Compared with siRNA422,siRNA710,vehicle or mismatch siRNA-treated group,the expression of caveolin-1 protein was the least after siRNA548 treatment 48 h later(P<0.01).Conclusions ① The siRNA548 can inhibit caveolin-1 expression most effectively in endothelial cells.② siRNA(20 nmol/L) combined with siRNAFect(1.3 μl) has lower cytotoxicity and higher transfection efficiency,which is suitable for transfection. Key words: Endothelial cells;  Caveolin-1 ;  Small interfering RNA;  Sulforhodamine B;  Cytotoxicity;  Election

Key concepts: Transfection, Sulforhodamine B, Small interfering RNA, Cytotoxicity, Molecular biology, RNA interference, Western blot, Messenger RNA

Related papers

Back to paper searchBrowse research topicsOriginal source
Selection of the most effective small interfering RNA which inhibits the expression of caveolin-1 in endothelial cells and detection of the cytotoxicity of transfection complex — Research Paper | ScholarLens